Key Decisions in HIV Care: Weight Gain in ART
Listen as Joseph J. Eron, Jr., MD, explores whether weight gain should or should not be a factor in determining initial therapy.
Decera Clinical Education Infectious Disease Podcast · Joseph J Eron MD
Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this episode, Joseph J. Eron, Jr., MD, explores whether weight gain should or should not be a factor in determining initial therapy.
Listen as he gives his perspectives on:
- Weight gain following ART initiation by ARV class and ARV drug
- Results of the ADVANCE and GEMINI-1 and -2 studies, with exploration of weight, risk of CVD and diabetes
- BMI changes in PWH
- DHHS and IAS-USA guidelines for initial therapy
Presenter:
Joseph J. Eron, MD
Professor of Medicine and Epidemiology
University of North Carolina
School of Medicine
Director, AIDS Clinical Trials Unit
University of North Carolina
Chapel Hill, North Carolina
Follow along with the slides at:
https://bit.ly/3DyLgA3
See the entire program at:
https://bit.ly/2TXTYWx
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.